Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-23-019050)

Filing Details

Accession Number:: 0001493152-23-019050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-25 15:10:46
Reporting Period:: 2023-05-25

Accepted Time:: 2023-05-25 15:10:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1535955	Lipocine Inc.	LPCN	Pharmaceutical Preparations (2834)	990370688

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579872	V. Mahesh Patel	675 Arapeen Drive Suite 202 Salt Lake City UT 84108	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-25	8,706	$5.03	107,418	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Prior to May 11, 2023, Mr. Patel held 1,678,090 shares of common stock. On May 11, 2023, the Company effected a reverse stock split at a ratio of 1-for17, which resulted in a change in Mr. Patel's shares of common stock to 98,712 as of May 11, 2023.